American Home Products
Executive Summary
Second quarter earnings reflect a $53 mil. charge against earnings for the estimated costs associated with the suspension of RotaShield rotavirus vaccine shipments (1"The Pink Sheet" July 19, p. 4). Worldwide net sales decreased 1% to $398.7 mil. for the second quarter based on the RotaShield charge and decreased agricultural and animal product sales, the company stated. Net income was $398.7 mil., down 24%. Pharmaceutical sales were up 8% for the second quarter to $2.24 bil., based on Effexor XR, Enbrel, Zosyn, Ziac, and generic product sales increases